Development of Radiocontrast Agents for Vascular Imaging: Progress to Date

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.2, Iss.6, 2002-01, pp. : 357-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date

By Valdez Glenn R.

CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. : 887-896

Adis International

Access to resources Recommend Favorite

HIV Vaccines: Progress to Date

By > Andersen Christopher R. Kelleher Anthony D.

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 387-414

Adis International

Access to resources Recommend Favorite

Recent Advances in the Development of Amyloid Imaging Agents

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-09 ,pp. : 1773-1789

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging

Current Medicinal Chemistry, Vol. 22, Iss. 29, 2015-01 ,pp. : 3390-3404

Bentham Science Publishers

Access to resources Recommend Favorite

Current progress towards the development of tyrosine kinase inhibitors as anticancer agents

By Bridges A.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 279-292

Informa Healthcare

Access to resources Recommend Favorite